Literature DB >> 22846895

Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation.

Aize Franciscus van der Meer1, Daniël J Touw, Marco A E Marcus, Cornelis Neef, Johannes H Proost.   

Abstract

BACKGROUND: Observational data sets can be used for population pharmacokinetic (PK) modeling. However, these data sets are generally less precisely recorded than experimental data sets. This article aims to investigate the influence of erroneous records on population PK modeling and individual maximum a posteriori Bayesian (MAPB) estimation.
METHODS: A total of 1123 patient records of neonates who were administered vancomycin were used for population PK modeling by iterative 2-stage Bayesian (ITSB) analysis. Cut-off values for weighted residuals were tested for exclusion of records from the analysis. A simulation study was performed to assess the influence of erroneous records on population modeling and individual MAPB estimation. Also the cut-off values for weighted residuals were tested in the simulation study.
RESULTS: Errors in registration have limited the influence on outcomes of population PK modeling but can have detrimental effects on individual MAPB estimation. A population PK model created from a data set with many registration errors has little influence on subsequent MAPB estimates for precisely recorded data. A weighted residual value of 2 for concentration measurements has good discriminative power for identification of erroneous records.
CONCLUSIONS: ITSB analysis and its individual estimates are hardly affected by most registration errors. Large registration errors can be detected by weighted residuals of concentration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22846895     DOI: 10.1097/FTD.0b013e3182616937

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  5 in total

1.  Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations.

Authors:  Pieter J Colin; Karel Allegaert; Alison H Thomson; Daan J Touw; Michael Dolton; Matthijs de Hoog; Jason A Roberts; Eyob D Adane; Masato Yamamoto; Dolores Santos-Buelga; Ana Martín-Suarez; Nicolas Simon; Fabio S Taccone; Yoke-Lin Lo; Emilia Barcia; Michel M R F Struys; Douglas J Eleveld
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

2.  Pharmacokinetic Modeling of Hydrocortisone by Including Protein Binding to Corticosteroid-Binding Globulin.

Authors:  Eric Rozenveld; Nieko Punt; Martijn van Faassen; André P van Beek; Daan J Touw
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

3.  Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting.

Authors:  Alper Daskapan; Desie Dijkema; Dorien A de Weerd; Wouter F W Bierman; Jos G W Kosterink; Tjip S van der Werf; Jan-Willem C Alffenaar; Ymkje Stienstra
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

4.  Evaluation of the Robustness of Therapeutic Drug Monitoring Coupled with Bayesian Forecasting of Busulfan with Regard to Inaccurate Documentation.

Authors:  Adrin Dadkhah; Dzenefa Alihodzic; Astrid Broeker; Nicolaus Kröger; Claudia Langebrake; Sebastian G Wicha
Journal:  Pharm Res       Date:  2021-10-18       Impact factor: 4.200

5.  Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing.

Authors:  Dzenefa Alihodzic; Astrid Broeker; Michael Baehr; Stefan Kluge; Claudia Langebrake; Sebastian Georg Wicha
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.